Literature DB >> 27601618

Human Alveolar Macrophages May Not Be Susceptible to Direct Infection by a Human Influenza Virus.

David B Ettensohn1, Mark W Frampton1, Joan E Nichols2, Norbert J Roberts3,2.   

Abstract

The current studies were undertaken to determine the susceptibility of human alveolar macrophages (AMs) to influenza A virus (IAV) infection in comparison with autologous peripheral blood-derived monocytes-macrophages (PBMs). AMs and PBMs were exposed to IAV in vitro and examined for their ability to bind and internalize IAV, and synthesize viral proteins and RNA. PBMs but not AMs demonstrated binding and internalization of the virus, synthesizing viral proteins and RNA. Exposure of AMs in the presence of a sialidase inhibitor or anti-IAV antibody resulted in viral protein synthesis by the cells. Exposure of AMs to fluorescein isothiocyanate-labeled IAV in the presence of anti-fluorescein isothiocyanate antibody also resulted in viral protein synthesis. Thus, human AMs are apparently not susceptible to direct infection by a human IAV but are likely to be infected indirectly in the setting of exposure in the presence of antibody that binds the challenging strain of IAV.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  human alveolar macrophages; influenza virus; macrophages; monocytes

Mesh:

Substances:

Year:  2016        PMID: 27601618      PMCID: PMC5144727          DOI: 10.1093/infdis/jiw413

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak.

Authors:  Zong-Mei Sheng; Daniel S Chertow; Xavier Ambroggio; Sherman McCall; Ronald M Przygodzki; Robert E Cunningham; Olga A Maximova; John C Kash; David M Morens; Jeffery K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.

Authors:  Keith C Meyer; Ganesh Raghu; Robert P Baughman; Kevin K Brown; Ulrich Costabel; Roland M du Bois; Marjolein Drent; Patricia L Haslam; Dong Soon Kim; Sonoko Nagai; Paola Rottoli; Cesare Saltini; Moisés Selman; Charlie Strange; Brent Wood
Journal:  Am J Respir Crit Care Med       Date:  2012-05-01       Impact factor: 21.405

3.  Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice.

Authors:  Yumi Hashimoto; Takeshi Moki; Takenori Takizawa; Akiko Shiratsuchi; Yoshinobu Nakanishi
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Monoclonal antibodies to the influenza A virus nucleoprotein affecting RNA transcription.

Authors:  K L van Wyke; W J Bean; R G Webster
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

6.  Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intra-alveolar administration of aerosolized heat-killed BCG.

Authors:  A Blussé van Oud Alblas; B van der Linden-Schrever; R Van Furth
Journal:  Am Rev Respir Dis       Date:  1983-08

7.  Influenza virus infection of desialylated cells.

Authors:  S J Stray; R D Cummings; G M Air
Journal:  Glycobiology       Date:  2000-07       Impact factor: 4.313

8.  Modifications of glycosylation patterns in macrophages upon activation.

Authors:  S Afroun; J P Tenu; G Lemaire
Journal:  Biochim Biophys Acta       Date:  1988-09-16

9.  Macrophages are required for influenza virus infection of human lymphocytes.

Authors:  D J Mock; F Domurat; N J Roberts; E E Walsh; M R Licht; P Keng
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

10.  The origin and virulence of the 1918 "Spanish" influenza virus.

Authors:  Jeffery K Taubenberger
Journal:  Proc Am Philos Soc       Date:  2006-03
View more
  7 in total

1.  The role of cell surface expression of influenza virus neuraminidase in induction of human lymphocyte apoptosis.

Authors:  Joan E Nichols; Jean A Niles; Elisa H Fleming; Norbert J Roberts
Journal:  Virology       Date:  2019-06-10       Impact factor: 3.616

2.  Influenza A viruses limit NLRP3-NEK7-complex formation and pyroptosis in human macrophages.

Authors:  Inês Boal-Carvalho; Béryl Mazel-Sanchez; Filo Silva; Laure Garnier; Soner Yildiz; Joao Ppl Bonifacio; Chengyue Niu; Nathalia Williams; Patrice Francois; Nicolaus Schwerk; Jennifer Schöning; Julia Carlens; Dorothee Viemann; Stephanie Hugues; Mirco Schmolke
Journal:  EMBO Rep       Date:  2020-11-12       Impact factor: 9.071

3.  Comparison of pro- and anti-inflammatory responses in paired human primary airway epithelial cells and alveolar macrophages.

Authors:  Reem Al Mubarak; Nicole Roberts; Robert J Mason; Scott Alper; Hong Wei Chu
Journal:  Respir Res       Date:  2018-06-25

Review 4.  The Role of Innate Leukocytes during Influenza Virus Infection.

Authors:  Prem P Lamichhane; Amali E Samarasinghe
Journal:  J Immunol Res       Date:  2019-09-12       Impact factor: 4.818

Review 5.  Immune Responses to IAV Infection and the Roles of L-Selectin and ADAM17 in Lymphocyte Homing.

Authors:  Sophie G Reed; Ann Ager
Journal:  Pathogens       Date:  2022-01-25

Review 6.  Diverse and Unexpected Roles of Human Monocytes/Macrophages in the Immune Response to Influenza Virus.

Authors:  Norbert J Roberts
Journal:  Viruses       Date:  2020-03-31       Impact factor: 5.048

7.  Influenza Virus Infection of Human Lymphocytes Occurs in the Immune Cell Cluster of the Developing Antiviral Response.

Authors:  David J Mock; Mark W Frampton; Joan E Nichols; Frank M Domurat; Denise J Signs; Norbert J Roberts
Journal:  Viruses       Date:  2018-08-10       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.